Literature DB >> 9634238

Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development.

Y R Zou1, A H Kottmann, M Kuroda, I Taniuchi, D R Littman.   

Abstract

Chemokines and their receptors are important in cell migration during inflammation, in the establishment of functional lymphoid microenvironments, and in organogenesis. The chemokine receptor CXCR4 is broadly expressed in cells of both the immune and the central nervous systems and can mediate migration of resting leukocytes and haematopoietic progenitors in response to its ligand, SDF-1. CXCR4 is also a major receptor for strains of human immunodeficiency virus-1 (HIV-1) that arise during progression to immunodeficiency and AIDS dementia. Here we show that mice lacking CXCR4 exhibit haematopoietic and cardiac defects identical to those of SDF-1-deficient mice, indicating that CXCR4 may be the only receptor for SDF-1. Furthermore, fetal cerebellar development in mutant animals is markedly different from that in wild-type animals, with many proliferating granule cells invading the cerebellar anlage. This is, to our knowledge, the first demonstration of the involvement of a G-protein-coupled chemokine receptor in neuronal cell migration and patterning in the central nervous system. These results may be important for designing strategies to block HIV entry into cells and for understanding mechanisms of pathogenesis in AIDS dementia.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9634238     DOI: 10.1038/31269

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  722 in total

Review 1.  The role of chemokine receptors in HIV infection.

Authors:  S Rowland-Jones
Journal:  Sex Transm Infect       Date:  1999-06       Impact factor: 3.519

Review 2.  Immune chemokines and their receptors: the key elements in the genesis, homeostasis and function of the immune system.

Authors:  O Yoshie
Journal:  Springer Semin Immunopathol       Date:  2000

Review 3.  Gene targeting of chemokines and their receptors.

Authors:  D M Slattery; N Gerard; C Gerard
Journal:  Springer Semin Immunopathol       Date:  2000

4.  CXC chemokine receptor 4 expression and stromal cell-derived factor-1alpha-induced chemotaxis in CD4+ T lymphocytes are regulated by interleukin-4 and interleukin-10.

Authors:  T Jinquan; S Quan; H H Jacobi; H O Madsen; C Glue; P S Skov; H J Malling; L K Poulsen
Journal:  Immunology       Date:  2000-03       Impact factor: 7.397

5.  The beta-chemokine receptor D6 is expressed by lymphatic endothelium and a subset of vascular tumors.

Authors:  R J Nibbs; E Kriehuber; P D Ponath; D Parent; S Qin; J D Campbell; A Henderson; D Kerjaschki; D Maurer; G J Graham; A Rot
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

6.  Induction of the chemokine stromal-derived factor-1 following DNA damage improves human stem cell function.

Authors:  T Ponomaryov; A Peled; I Petit; R S Taichman; L Habler; J Sandbank; F Arenzana-Seisdedos; A Magerus; A Caruz; N Fujii; A Nagler; M Lahav; M Szyper-Kravitz; D Zipori; T Lapidot
Journal:  J Clin Invest       Date:  2000-12       Impact factor: 14.808

Review 7.  Regulation of hematopoiesis by chemokine family members.

Authors:  H E Broxmeyer
Journal:  Int J Hematol       Date:  2001-07       Impact factor: 2.490

8.  Thymocyte emigration is mediated by active movement away from stroma-derived factors.

Authors:  Mark C Poznansky; Ivona T Olszak; Richard H Evans; Zhengyu Wang; Russell B Foxall; Douglas P Olson; Kathryn Weibrecht; Andrew D Luster; David T Scadden
Journal:  J Clin Invest       Date:  2002-04       Impact factor: 14.808

9.  Chemorepulsion and thymocyte emigration.

Authors:  Jason G Cyster
Journal:  J Clin Invest       Date:  2002-04       Impact factor: 14.808

10.  Stromal-cell derived factor is expressed by dendritic cells and endothelium in human skin.

Authors:  J L Pablos; A Amara; A Bouloc; B Santiago; A Caruz; M Galindo; T Delaunay; J L Virelizier; F Arenzana-Seisdedos
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.